The pathogenic role of angiogenesis in rheumatoid arthritis
- PMID: 26198292
- PMCID: PMC4879881
- DOI: 10.1007/s10456-015-9477-2
The pathogenic role of angiogenesis in rheumatoid arthritis
Abstract
Angiogenesis is the formation of new capillaries from pre-existing vasculature, which plays a critical role in the pathogenesis of several inflammatory autoimmune diseases such as rheumatoid arthritis (RA), spondyloarthropathies, psoriasis, systemic lupus erythematosus, systemic sclerosis, and atherosclerosis. In RA, excessive migration of circulating leukocytes into the inflamed joint necessitates formation of new blood vessels to provide nutrients and oxygen to the hypertrophic joint. The dominance of the pro-angiogenic factors over the endogenous angiostatic mediators triggers angiogenesis. In this review article, we highlight the underlying mechanisms by which cells present in the RA synovial tissue are modulated to secrete pro-angiogenic factors. We focus on the significance of pro-angiogenic factors such as growth factors, hypoxia-inducible factors, cytokines, chemokines, matrix metalloproteinases, and adhesion molecules on RA pathogenesis. As pro-angiogenic factors are primarily produced from RA synovial tissue macrophages and fibroblasts, we emphasize the key role of RA synovial tissue lining layer in maintaining synovitis through neovascularization. Lastly, we summarize the specific approaches utilized to target angiogenesis. We conclude that the formation of new blood vessels plays an indispensable role in RA progression. However, since the function of several pro-angiogenic mediators is cross regulated, discovering novel approaches to target multiple cascades or selecting an upstream cascade that impairs the activity of a number of pro-angiogenic factors may provide a promising strategy for RA therapy.
Keywords: Angiogenesis; Chemokines; Cytokines; Growth factors; Matrix metalloproteinases and adhesion molecules; RA.
Figures
Similar articles
-
Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis.Arthritis Res Ther. 2009;11(3):R64. doi: 10.1186/ar2689. Epub 2009 May 8. Arthritis Res Ther. 2009. PMID: 19426483 Free PMC article.
-
Enhanced angiogenic function in response to fibroblasts from psoriatic arthritis synovium compared to rheumatoid arthritis.Arthritis Res Ther. 2019 Dec 21;21(1):297. doi: 10.1186/s13075-019-2088-3. Arthritis Res Ther. 2019. PMID: 31864394 Free PMC article.
-
Oxidative stress impairs energy metabolism in primary cells and synovial tissue of patients with rheumatoid arthritis.Arthritis Res Ther. 2018 May 29;20(1):95. doi: 10.1186/s13075-018-1592-1. Arthritis Res Ther. 2018. PMID: 29843785 Free PMC article.
-
Angiogenesis in rheumatoid arthritis.Front Biosci. 2005 May 1;10:1739-53. doi: 10.2741/1657. Front Biosci. 2005. PMID: 15769663 Review.
-
New insights in synovial angiogenesis.Joint Bone Spine. 2010 Jan;77(1):13-9. doi: 10.1016/j.jbspin.2009.05.011. Epub 2009 Dec 21. Joint Bone Spine. 2010. PMID: 20022538 Free PMC article. Review.
Cited by
-
Complement factor H in molecular regulation of angiogenesis.Med Rev (2021). 2024 Jul 1;4(5):452-466. doi: 10.1515/mr-2023-0048. eCollection 2024 Oct. Med Rev (2021). 2024. PMID: 39444793 Free PMC article. Review.
-
Sera from Rheumatoid Arthritis Patients Induce Oxidative Stress and Pro-Angiogenic and Profibrotic Phenotypes in Human Endothelial Cells.J Clin Med. 2024 Oct 3;13(19):5913. doi: 10.3390/jcm13195913. J Clin Med. 2024. PMID: 39407973 Free PMC article.
-
In-silico analysis predicts disruption of normal angiogenesis as a causative factor in osteoporosis pathogenesis.BMC Genom Data. 2024 Oct 8;25(1):85. doi: 10.1186/s12863-024-01269-z. BMC Genom Data. 2024. PMID: 39379846 Free PMC article.
-
JAK inhibitors inhibit angiogenesis by reducing VEGF production from rheumatoid arthritis-derived fibroblast-like synoviocytes.Clin Rheumatol. 2024 Nov;43(11):3525-3536. doi: 10.1007/s10067-024-07142-9. Epub 2024 Sep 20. Clin Rheumatol. 2024. PMID: 39302595
-
Antiarthritic and Antinociceptive Properties of Ylang-Ylang (Cananga odorata) Essential Oil in Experimental Models.Curr Issues Mol Biol. 2024 Aug 18;46(8):9033-9046. doi: 10.3390/cimb46080534. Curr Issues Mol Biol. 2024. PMID: 39194751 Free PMC article.
References
-
- Szekanecz Z, Koch AE. Mechanisms of Disease: angiogenesis in inflammatory diseases. Nat Clin Pract Rheumatol. 2007;3(11):635–643. - PubMed
-
- Folkman J, Klagsbrun M. Angiogenic factors. Science. 1987;235(4787):442–447. - PubMed
-
- Lainer-Carr D, Brahn E. Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis. Nat Clin Pract Rheumatol. 2007;3(8):434–442. - PubMed
-
- Koch AE. Angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum. 1998;41(6):951–962. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials